Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/sciences-de-la-vie/therapeutic-drug-monitoring-data/descriptif_4217660
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4217660

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Therapeutic Drug Monitoring Data (4th Ed.) A Concise Guide

Langue : Anglais

Auteurs :

Couverture de l’ouvrage Therapeutic Drug Monitoring Data

Therapeutic Drug Monitoring Data: A Concise Guide, Fourth Edition serves as a ready resource of information on commonly monitored drugs that will help readers make decisions relating to the monitoring and interpretation of results. It is an easy-to-read source of information on intended use, pharmacokinetics, therapeutic range, and toxic concentrations, as well as bioavailability, disposition, metabolism and the excretion of commonly monitored therapeutic drugs. This fully updated fourth edition includes sections on new anticonvulsants, anti-depressant and anti-HIV drugs, new drugs for advanced cancer treatment, and thoroughly updated chapters that address new pitfalls and problems in the lab.

1. Pharmacokinetics and Therapeutic Drug Monitoring2. Before and After: The Preanalytical and Postanalytical Phases of Therapeutic Drug Monitoring3. Clinical Utility of Monitoring Free Drug Concentrations4. Effect of Bilirubin, Lipemia, Hemolysis, Paraproteins, and Heterophilic Antibodies on Immunoassays for Therapeutic Drug Monitoring5. Drug-Herb and Drug-Food Interactions and Effects on Therapeutic Drug Monitoring6. Monitoring Anticonvulsant Concentrations – General Considerations7. Therapeutic Drug Monitoring of Cardioactive Drugs8. Therapeutic Drug Monitoring of Antidepressants9. Introduction to Immunosuppressive Drug Monitoring10. Therapeutic Drug Monitoring of Antimicrobial and Antiviral Agents11. Therapeutic Drug Monitoring of Analgesics12. Therapeutic Drug Monitoring of Antineoplastic Drugs13. Caffeine, Lithium, and Theophylline
Pathologists, clinical chemists, and toxicologists; practicing clinicians, fellows and residents in pathology, internal medicine, emergency medicine and family practice

Amitava Dasgupta received his Ph. D in chemistry from Stanford University and completed his fellowship training in Clinical Chemistry from the Department of Laboratory Medicine at the University of Washington School of Medicine at Seattle. He is board certified in both Toxicology and Clinical Chemistry by the American Board of Clinical Chemistry. Currently, he is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Kansas Medical Center and Director of Clinical Laboratories at the University of Kansas Hospital. Prior to this appointment he was a tenured Professor of Pathology and Laboratory Medicine at the University of Texas McGovern medical School from February 1998 to April 2022. He has 252 papers to his credit. He is in the editorial board of four journals including Therapeutic Drug Monitoring, Clinica Chimica Acta, Archives of Pathology and Laboratory Medicine, and Journal of Clinical Laboratory Analysis.


Matthew D. Krasowski, MD, PhD is a clinical pathologist and the Walter L. Bierring Professor of Clinical Education at the University of Iowa Carver College of Medicine. He currently serves as the Vice Chair of Clinical Pathology and Laboratory Services in the Department of Pathology at University of Iowa Hospitals and Clinics.
  • Serves as a ready resource of information for commonly monitored drugs
  • Presents a useful, quick guide for those making decisions related to monitoring and interpretation of results
  • Provides concise, easily digestible content for clinical laboratory scientists, toxicologists and clinicians